A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis)
Status: Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2019
Price : $35 *
At a glance
- Drugs SVT-15652 (Primary)
- Indications Mycoses; Otitis externa
- Focus Therapeutic Use
- Acronyms CLEAR-1
- Sponsors SALVAT
- 05 Apr 2019 Planned End Date changed from 1 Feb 2020 to 1 Nov 2020.
- 05 Apr 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Oct 2020.
- 05 Apr 2019 Planned initiation date changed from 1 Jan 2019 to 1 Sep 2019.